This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Protecting Pregnant Women with HIV and Their Infants Against Pneumococcus
April 29, 2021
Pneumococcus is a significant danger to pregnant women with HIV and their infants. PCV-10 and PPV-23 are 2 vaccines that help protect against invasive disease like pneumococcus. New research has compared the safety and immunogenicity of PCV-10 and PPV-23 administered in pregnancy.
In a new article published in the Lancet, Westat’s Lauren Laimon, M.S., Lassallete Newton, and coauthors note that PCV-10 and PPV-23 were equally safe and immunogenic in pregnant women with HIV and conferred similar levels of seroprotection to their infants. Learn more: Safety, Immunogenicity, and Transplacental Antibody Transport of Conjugated and Polysaccharide Pneumococcal Vaccines Administered to Pregnant Women With HIV: A Multicentre Randomized Controlled Trial.
Focus Areas
Clinical Research